Neurotropin [NT3] for acute dental pain and for chronic neuropathic pain.

Trial Profile

Neurotropin [NT3] for acute dental pain and for chronic neuropathic pain.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 08 Feb 2017

At a glance

  • Drugs Neurotropin (Primary)
  • Indications Complex regional pain syndromes; Dental pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Jun 2012 Planned end date (Jun 2012) added as reported by ClinicalTrials.gov.
    • 21 Jun 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
    • 06 Jun 2012 Additional lead trial investigator (John D Heiss) identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top